Robert Johnson

Robert G. Johnson, MD, PhD has a vast amount of experience in the biopharmaceutical industry. Currently serving as the COO at GenVivo, Inc., Robert also holds various leadership positions at organizations such as the University of Pennsylvania Perelman School of Medicine and the Hope Funds for Cancer Research. Additionally, Robert G. is the principal at Aeolian Biomed, providing consulting services for the industry. With a background in medicine and biophysics, Robert has held top executive positions at companies like Epeius Biotechnologies Corp., Kosan Biosciences, Chiron Corporation, and Merck.